Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Jan-Dec:54:19160216241307553.
doi: 10.1177/19160216241307553.

Optokinetic After-Nystagmus: A Marker for Migraine? A Prospective Observational Study

Affiliations
Observational Study

Optokinetic After-Nystagmus: A Marker for Migraine? A Prospective Observational Study

Mikaël Kassin-Dufresne et al. J Otolaryngol Head Neck Surg. 2025 Jan-Dec.

Abstract

Introduction: Vestibular migraine (VM), particularly its chronic variant, poses a diagnostic challenge. Patients suffering from VM may not have the characteristic headaches associated with the dizziness. In these cases, a marker for migraine pathology in general could help appropriately diagnose certain types of dizziness as migrainous despite these patients not meeting current diagnostic criteria for VM. Migraine patients in general (headache and vestibular) are known to share a tendency toward intolerance of certain stimuli, including busy visual stimuli. True optokinetic stimulation, measured by the production of optokinetic after-nystagmus (OKAN) simulates these busy visual stimuli.

Methods: Prospective observational study comparing response to optokinetic stimulation between migraine patients and controls. Questionnaires regarding general sensitivities to busy visual stimuli were completed prior to beginning the study. Both subjective and objective markers of stress were measured before and after exposure to the stimulus. Initial slow-phase velocity, slow cumulative eye position, and adjusted time constant of OKAN were compared between the 2 groups.

Results: The groups differed only with regard to sensitivity to blinking lights and history of motion sickness on initial questionnaire. Regarding subjective symptoms of discomfort, migraine patients tended to report higher scores than controls both before and after testing, but there was no significant difference from before to after stimulus in each group's scores. There were no statistically-significant differences between initial slow-phase velocity, slow cumulative eye position, and adjusted time constant of OKAN between groups.

Conclusions: In this study, OKAN measurements were not useful in differentiating migraine patients at large from control subjects. We hypothesize that there may be a distinct subgroup of migraine patients that are more sensitive to visually-disturbing situations that may differ from other migraine sufferers. Future studies will aim to identify such patients and compare them to controls.

Keywords: OKAN; migraine; migraine-related dizziness; migrainous vertigo; optokinetic after-nystagmus; vestibular migraine.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Graphical abstract
Graphical abstract
Figure 1.
Figure 1.
Timeline of evaluation for each subject.
Figure 2.
Figure 2.
Salivette® from Starstedt, Inc, used to obtain saliva from subjects for salivary cortisol measurements.
Figure 3.
Figure 3.
Apparatus designed and manufactured for OKN/OKAN stimulation for this study. (a) View of exterior setting with evaluator, VNG hardware, and rotating drum. (b) View inside of rotating drum with subject seated inside of drum. (c) Initial conception design. OKN, optokinetic nystagmus; OKAN, optokinetic after-nystagmus; VNG, videonystagmography.

Similar articles

Cited by

References

    1. Burch RC, Loder S, Loder E, Smitherman TA. The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache. 2015;55:21-34. - PubMed
    1. Ramage-Morin PL, Gilmour H. Prevalence of migraine in the Canadian household population. Health Rep. 2014;25(6):10-16. - PubMed
    1. Kayan A, Hood JD. Neuro-otological manifestations of migraine. Brain. 1984;107:1123-1142. - PubMed
    1. Drummond PD. Motion sickness and migraine: optokinetic stimulation increases scalp tenderness, pain sensitivity in the fingers and photophobia. Cephalalgia. 2002;22(2):117-124. - PubMed
    1. Drummond PD, Granston A. Facial pain increases nausea and headache during motion sickness in migraine sufferers. Brain. 2004;127(3):526-534. - PubMed

Publication types

LinkOut - more resources